SUMMARY. A review is given of the biochemical background of the glycosylated haemoglobins, their methods of determination, and their clinical significance. Special attention is paid to the sample preparation. For all methods except the colorimetric TBA-method, the removal of the labile pre-HbA1c fraction is essential. Under proper conditions, high-performance liquid chromatography, agar-gel electrophoresis and affinity chromatography are suitable methods for use in the clinical laboratory for the estimation of HbA 1c and HbA 1. However, the colorimetric TBA-method must be considered to be the method of choice. The clinical utility of the test is stressed with special respect to the management of diabetic pregnancies, the control of home-monitoring of blood glucose, and the objective measurement of the effect of changing diabetic therapy.Despite increasing understanding of the pathogenesis and therapy of diabetes mellitus, the most important question concerning the relationship between the degree of metabolic control and the occurrence of long-term complications of diabetes is still not answered. The lack of satisfactory methods for the quantitative assessment of diabetic control was one of the main reasons for the difficulty in resolving this problem.Nowadays, the measurement of glycosylated haemoglobin (HbA 1c, HbA 1 ) is becoming widely accepted as an objective and quantitative index of blood glucose levels during the preceding six to ten weeks. This review discusses the structure and biosynthesis of glycosylated haemoglobins, the methods available for their measurement, and the clinical usefulness of measuring glycosylated haemoglobin.Structure and biosynthesis HISTORY Heterogeneity of human haemoglobins has been reported by several investigators. Schroeder and his colleagues,1-3 using column chromatography on weak-cation exchange resins, isolated several minor fractions from adult red cell haemolysates. These minor fractions elute before the main component HbA o (nomenclature according to Huisman and Dozy") and are therefore called 'fast' haemoglobins, At least three different fractions, HbA 1a, HbA l b and 2 HbA1c, were identified. These findings were confirmed by Huisman et al.,45 who already in 1962 reported an increase in the fast-moving Hb in four diabetic patients who had been treated with tolbutamide. This increase was attributed to the reaction of tolbutamide to HbAo.The finding of the 'diabetic haemoglobin components' was reported by Rahbar," who found in both agar and cellulose acetate electrophoresis a , negatively charged haemoglobin band in blood samples of several patients with diabetes mellitus. Soon it was demonstrated that the diabetic component had a chromatographic characteristic similar to that of HbA\c, theminor Hbcomponent previously described by Schnek and Schroeder." Structural studies later established that the diabetic haemoglobin was indeed identical with HbA\c. 7
BIOCHEMISTRYIn human adults, more than 90 % of haemoglobin is HbAo, a tetrameric molecule, composed of two pairs ...